Invitae
NVTA
$0.01950
Share price
0.00%
Change (1 day)
-98.61%
Change (1 year)
Invitae (NVTA) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $1.61 B
According to Invitae 's latest financial reports the company's total liabilities are $1.61 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Invitae - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $1.85 B | -4.58% |
| 2021-12-31 | $1.94 B | 33.49% |
| 2020-12-31 | $1.45 B | 261.77% |
| 2019-12-31 | $0.40 B | 231.87% |
| 2018-12-31 | $0.12 B | 35.66% |
| 2017-12-31 | $89.28 M | 182.75% |
| 2016-12-31 | $31.57 M | 72.55% |
| 2015-12-31 | $18.3 M | -91.38% |
| 2014-12-31 | $0.21 B | 134.95% |
| 2013-12-31 | $90.38 M | 133.35% |
| 2012-12-31 | $38.73 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Celldex Therapeutics CLDX | $36.45 M | -97.75% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | $10.39 M | -99.36% | 🇺🇸 USA |
 CareDx CDNA | $0.20 B | -87.30% | 🇺🇸 USA |